Taxol (Generic name for paclitaxel) is a complicated diterpene compound that is initially isolated from yew plants. Taxol is one of the most exciting natural ingredients to treat various cancers, including breast cancer, ovarian carcinoma, melanoma, and lung cancer. Limited number of yew trees, low content of taxol in plant tissue, slow growing and killing the tree to bark harvesting are significant restrictions that have led to the supply and availability of this important substance faced with challenges. Many attempts to complete synthesis, semi-synthesis, finding new source e.g alternative spices, other plant, microorganisms and establishment of the cell suspension cultures have been carried out. Cell culture is an appropriate strategy for stable production by using a small part of the plant as explants. Elicitors such as methyl jasmonate family compounds are powerfull stimulator for production of taxol. Methyl jasmonate increases the amount of taxol by enhancing the expression levels of taxol biosynthesis enzymes such as Geranyl-geranyl pyrophosphate synthase (GGPPs) and taxadienesynthesis (TDS). New approach including genetic and metabolic engineering can be led to increasing the taxol production by the over-expression of genes controlling limiting steps or by suppressing the undesired taxanes by employing antisense technology. The yew-coding genes associated with the production of taxol have been cloned. However, genetic manipulation strategies are not yet complete. This paper reviews the various ways to improve Taxol production.